Latest Breaking News On - Venture investment - Page 15 : comparemela.com

ACTICOR BIOTECH: Half-Year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux

ACTICOR BIOTECH: Half-Year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomNewton biocapitalKepler cheuvreuxVenture investmentFrench national institute of healthEuropean medicines agencyFrench national instituteMedical researchActicor biotechEuronext growth paris

ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of December 31, 2023

ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of December 31, 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomFrance generalNewton biocapitalStefan klotterRegulation of the french financial markets authorityFrench national institute of healthEuropean medicines agencyVenture investmentRegulatory newsFrench commercial codeGeneral regulationFrench financial markets authorityEuronext growth parisFrench national instituteMedical researchActicor biotech

ACTICOR BIOTECH: Half-Year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux

ACTICOR BIOTECH: Half-Year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomNewton biocapitalStefan klotterKepler cheuvreuxVenture investmentFrench national institute of healthEuropean medicines agencyRegulatory newsFrench national instituteMedical researchActicor biotechEuronext growth parisDie performance strategieAssets sie

ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of December 31, 2023

ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of December 31, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomNewton biocapitalEuropean medicines agencyVenture investmentFrench national institute of healthRegulation of the french financial markets authorityFrench commercial codeGeneral regulationFrench financial markets authorityEuronext growth parisFrench national instituteMedical researchActicor biotech

ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of December 31, 2023

17.01.2024 - Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, today discloses the total number of voting .

United kingdomNewton biocapitalEuropean medicines agencyVenture investmentFrench national institute of healthFrench national instituteMedical researchActicor biotechEuronext growth parisActicor biotech stockEuronext paris